搜尋結果
Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030
CNBC· 7 小時前AstraZeneca CEO Pascal Soriot explained in a Tuesday interview with CNBC's Jim Cramer why ...
Astra's Enhertu delays breast cancer in patients with low HER2 levels
Reuters· 3 日前The findings, presented in Chicago at the annual meeting of the American Society of Clinical ...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters· 5 日前Shares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the ...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 5 日前, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer ...